Anastomosis Device Market Worth $2.9 Billion by 2024 - Exclusive Report by MarketsandMarkets(TM)

CHICAGO, Oct. 4, 2019 /PRNewswire/ -- According to the new market research report "Anastomosis Device Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable), and Surgical Sealants and Adhesives, Application (GI, CVD, Other), & End Users (Hospital, ASCs/Clinic) - Global Forecast to 2024", published by MarketsandMarkets(TM), the global Anastomosis Devices Market is projected to reach USD 2.9 billion by 2024 from an estimated USD 2.1 billion in 2019, at a CAGR of 7.2% during the forecast period.

Download PDF Brochure:

The growth of this market is primarily driven by the increasing incidence of target diseases and the subsequent growth in the number of surgical procedures, growing demand for minimally invasive surgeries, and technological advancements.

By type, the surgical staplers segment accounted for the largest share of the market in 2018.

Based on type, the Anastomosis Device Market is segmented into surgical staplers, surgical sutures, and surgical sealants & adhesives. Of all these segments, surgical staplers accounted for the largest share of the Anastomosis Devices Market in 2018. The large share of this segment can be attributed to the advantages associated with surgical staplers (ease of use, minimal risk of complications, reduced blood loss/leakage, and shorter operating time) in comparison with surgical sutures and surgical sealants and adhesives.

Browse in-depth TOC on "Anastomosis Device Market"

292 - Tables

31 - Figures

218 - Pages

By application, the gastrointestinal surgeries segment dominated the market in 2018.

Based on application, the market is segmented into gastrointestinal surgeries, cardiovascular & thoracic surgeries, and other applications. Gastrointestinal surgeries accounted for the largest share of the Anastomosis Devices Market in 2018. The large share of this segment can be attributed to the rising incidence of gastrointestinal cancer and the extensive usage of anastomosis devices in these surgical procedures.

Hospitals accounted for the largest market share in 2018.

Based on end user, the market is segmented into hospitals and ambulatory surgical centers (ASCs) & clinics. Hospitals commanded the largest share of the Anastomosis Devices Market in 2018. The large share of this end-user segment can be attributed to the increasing number of hospitals, high patient preference for hospital treatment, and the availability of skilled healthcare professionals & technologically advanced facilities.

Get 10% Customization on this Research Report:

North America dominated the market in 2018.

In 2018, North America accounted for the largest share of the Anastomosis Devices Market, followed by Europe. Factors such as the presence of advanced healthcare infrastructure in the region, increasing incidence of target diseases, growth in the number of cancer cases, increasing number of organ transplants, and the implementation of a new funding model for Canadian hospitals are contributing to the large share of North America.

The key players in the global Anastomosis Device Market are Johnson & Johnson (US), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Smith & Nephew (UK), EndoEvolution LLC (US), CryoLife, Inc. (US), Becton, Dickinson and Company (US), CONMED Corporation (US), Intuitive Surgical, Inc. (US), Boston Scientific Corporation (US), Baxter International, Inc. (US), Péters Surgical (France), Biosintex (Romania), and Meril Life Sciences (India).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Surgical Suture Market by Product (Automated Suturing Device (Disposable, Reuse), Suture Thread (Natural, Nylon, Prolene, Stainless Steel, Silk)), Application (Cardiac, Gynae, Ophthalmic, Orthopedic), End User (Hospital, Clinic) - Global Forecast to 2023

Surgical Sealants and Adhesives Market by Product (Natural & Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Albumin, Human blood), Indication (Hemostasis, Tissue Sealing), Application (CNS, Cardiovascular, Cosmetic Surgery) - Global Forecast to 2021

About MarketsandMarkets(TM)

MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Mr. Shelly Singh
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Research Insight:
Visit Our Website:
Content Source:

View original content:

SOURCE MarketsandMarkets